GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
Advances in Neurological Disease Detection: A New Era of Precision and Early Intervention
Neurological diseases, encompassing a vast spectrum of disorders affecting the brain, spinal cord, and peripheral nerves, pose a significant and growing global health challenge. Conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and stroke not only inflict immense personal suffering but also place a substantial burden on healthcare systems
Double the Words, Double the Wits: Why Being Bilingual Really Does Seem to Delay Dementia
This is, in a simplified way, what speaking two languages does to your brain. And for years, scientists have been noticing something fascinating about this dual-language metropolis: its inhabitants seem to enjoy a longer lease on their cognitive prime, particularly when it comes to the specter of dementia.
A Drop in the Bucket: Blood Tests and the Evolving Landscape of Alzheimer's Diagnosis
The world of Alzheimer's research is constantly evolving, a relentless pursuit of unraveling the complexities of this devastating neurodegenerative disease. Just recently, a significant milestone was reached, one that could potentially reshape the way we approach diagnosis. The Food and Drug Administration (FDA)
Why New Alzheimer’s Treatments are Leaving Atypical Patients Behind
There is a massive blind spot in the current landscape of neurodegenerative care, and it’s one that should keep every health-tech developer awake at night. For decades, the public and medical consciousness has viewed Alzheimer’s disease through a single, narrow lens: the loss of memory. We imagine the grandmother who forgets a name or the father who loses his keys.
A Legacy of Mistrust: Understanding and Addressing Vaccine Hesitancy Among People of Color
The recent COVID-19 pandemic has laid bare a stark reality: people of color (POC) are disproportionately hesitant to engage with medical and governmental institutions, particularly regarding vaccinations. This hesitancy, often labeled as "vaccine hesitancy," is not simply a matter of ignorance or fear. It is rooted in a deeply ingrained distrust that stems from a long history of systemic racism and medical discrimination.
Finding Inner Peace: Contemplative Meditation for Alzheimer's Caregivers
Caring for a loved one with Alzheimer's disease can be an emotionally and physically exhausting journey. The constant demands, coupled with the heartbreak of witnessing the gradual decline of a once-familiar person, can take a significant toll on caregivers' well-being.
AI in Mental Health: Revolutionizing Care and Understanding
We stand at a pivotal moment in what is often called the "digital revolution," an era characterized by the blending of various technologies. A prime example of this technological fusion is Artificial Intelligence (AI), a concept first recognized in 1956